Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination
Unique ID
C000629984
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629984
Entry Term(s)
Symfi
Symfi Lo
Pharm Action
Reverse Transcriptase Inhibitors
Anti-HIV Agents
Anti-Retroviral Agents
Registry Numbers
0
Heading Mapped to
Drug Combinations
*Lamivudine
*Benzoxazines
*Tenofovir
Frequency
1
Note
once-daily fixed-dose antiretroviral drug combination for treatment of
HIV
infection; Symfi Lo contains a lower dose of efavirenz
Source
Med Lett Drugs Ther. 2019 Jan 14;61(1563):e8-e10.
Date of Entry
2019/02/22
Revision Date
2019/02/22
Expand All
Collapse All
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination
Preferred
Concept UI
M000647299
Registry Numbers
0
Terms
efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination
Preferred Term
Term UI
T000952070
Date
02/22/2019
LexicalTag
NON
ThesaurusID
NLM (2019)
Symfi
Narrower
Concept UI
M000647300
Terms
Symfi
Preferred Term
Term UI
T000952071
Date
02/22/2019
LexicalTag
TRD
ThesaurusID
NLM (2019)
Symfi Lo
Narrower
Concept UI
M000647301
Terms
Symfi Lo
Preferred Term
Term UI
T000952072
Date
02/22/2019
LexicalTag
TRD
ThesaurusID
NLM (2019)
page delivered in 0.005s